<code id='74A0F435A6'></code><style id='74A0F435A6'></style>
    • <acronym id='74A0F435A6'></acronym>
      <center id='74A0F435A6'><center id='74A0F435A6'><tfoot id='74A0F435A6'></tfoot></center><abbr id='74A0F435A6'><dir id='74A0F435A6'><tfoot id='74A0F435A6'></tfoot><noframes id='74A0F435A6'>

    • <optgroup id='74A0F435A6'><strike id='74A0F435A6'><sup id='74A0F435A6'></sup></strike><code id='74A0F435A6'></code></optgroup>
        1. <b id='74A0F435A6'><label id='74A0F435A6'><select id='74A0F435A6'><dt id='74A0F435A6'><span id='74A0F435A6'></span></dt></select></label></b><u id='74A0F435A6'></u>
          <i id='74A0F435A6'><strike id='74A0F435A6'><tt id='74A0F435A6'><pre id='74A0F435A6'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:74552
          gantenerumab Alzheimer's disease Roche
          Sebastien Bozon/AFP via Getty Images

          Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases. 

          Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world. 

          advertisement

          The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags
          Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

          3:30FILE-PeopleonbothsidesofthedebaterallyoutsidetheSupremeCourtinWashington,Monday,Dec.5,2022.Inade

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          For Cytokinetics, FDA rejection of heart drug would help, not hinder

          MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T